Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

SILO

Silo Pharma (QB) (SILO)

Silo Pharma Inc (QB)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:SILO
일자시간출처헤드라인심볼기업
2023/06/3005:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2023/05/2705:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
2023/05/1905:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
2023/02/1606:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2023/02/1506:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SILOSilo Pharma Inc (QB)
2023/02/0322:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2023/02/0106:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2023/01/2022:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2022/12/1606:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
2022/12/0206:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2022/11/1106:49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
2022/10/1906:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2022/09/3021:46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2022/09/2905:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:SILOSilo Pharma Inc (QB)
2022/09/2721:30Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)USOTC:SILOSilo Pharma Inc (QB)
2022/09/2719:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:SILOSilo Pharma Inc (QB)
2022/09/2705:01Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)USOTC:SILOSilo Pharma Inc (QB)
2022/09/0919:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
2022/08/2919:17Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
2022/08/0205:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
2022/07/2520:13Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
2022/06/2121:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
2022/05/1405:19Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
2022/03/1206:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
2022/03/0807:26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:SILOSilo Pharma Inc (QB)
2022/02/1507:43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:SILOSilo Pharma Inc (QB)
2022/01/0608:19Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:SILOSilo Pharma Inc (QB)
2021/12/1603:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
2021/11/1107:15Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
2021/10/2805:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
 검색 관련기사 보기:USOTC:SILO